Bristol Myers Gets CHMP Backing for Augtyro Cancer Drug

By MarketWatch | Nov 15, 2024 at 07:34 AM EST

Bristol Myers Squibb received a positive recommendation from the EMA for expanded approval of its cancer drug Augtyro in Europe. The drug may soon be approved for treating specific types of lung cancer and solid tumors, with potential to be a leading treatment in the EU.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.